Global Longlife Hosp
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Trade Pulse Broking Pvt Ltd acquired 268,000 shares of Global Longlife Hospital and Research Ltd in the open market on August 7, taking its holding from 500,000 shares, or 4.76%, to 768,000 shares, or 7.31%. The acquirer was not part of the promoter group.
Powered by Tijori
Trade Pulse Broking Pvt Ltd acquired 268,000 shares of Global Longlife Hospital and Research Ltd in the open market on August 7, taking its holding from 500,000 shares, or 4.76%, to 768,000 shares, or 7.31%. The acquirer was not part of the promoter group.
Powered by Tijori
Global Longlife Hospital and Research promoter Dhruv Sureshkumar Jani sold 7,22,000 shares, representing 6.88% of the company, in open-market transactions between August 10 and 12, 2026. His holding fell from 7,22,990 shares, or 6.89%, to 990 shares, or 0.01%.
Powered by Tijori
Global Longlife Hospital and Research promoter Dhruv Sureshkumar Jani sold 7,22,000 shares, representing 6.88% of the company, in open-market transactions between August 10 and 12, 2026. His holding fell from 7,22,990 shares, or 6.89%, to 990 shares, or 0.01%.
Powered by Tijori
Global Longlife Hospital and Research promoter Dhruv Sureshkumar Jani sold 10,00,000 shares, or 9.52% of the company, through open-market trades on August 6 and 7, 2026. His holding fell from 16.41% to 6.89% of the company's equity.
Powered by Tijori
Global Longlife Hospital and Research promoter Dhruv Sureshkumar Jani sold 10,00,000 shares, or 9.52% of the company, through open-market trades on August 6 and 7, 2026. His holding fell from 16.41% to 6.89% of the company's equity.
Powered by Tijori
June 26 (Reuters) - Global Longlife Hospital and Research Ltd GLOO.BO:
GLOBAL LONGLIFE HOSPITAL AND RESEARCH LTD- DHRUV JANI APPOINTED AS MANAGING DIRECTOR FOR FIVE YEARS
Source text: ID:nBSE42Z7RL
Further company coverage: GLOO.BO
(([email protected];))
June 26 (Reuters) - Global Longlife Hospital and Research Ltd GLOO.BO:
GLOBAL LONGLIFE HOSPITAL AND RESEARCH LTD- DHRUV JANI APPOINTED AS MANAGING DIRECTOR FOR FIVE YEARS
Source text: ID:nBSE42Z7RL
Further company coverage: GLOO.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Global Longlife Hosp do?
Global Longlife Hospital provides a range of healthcare services including oncology, cardiology, and surgery. It is certified by NABH and has invested in an IT system for clinical and administrative functions.
Who are the competitors of Global Longlife Hosp?
Global Longlife Hosp major competitors are Family Care Hospital, Tejnaksh Healthcare, Fortis MalarHospital, Aashka Hospitals, Shalby, KMC Speciality Hosp., Dr Agarwals Eye Hosp. Market Cap of Global Longlife Hosp is ₹16 Crs. While the median market cap of its peers are ₹195 Crs.
Is Global Longlife Hosp financially stable compared to its competitors?
Global Longlife Hosp seems to be less financially stable compared to its competitors. Altman Z score of Global Longlife Hosp is 0 and is ranked 6 out of its 8 competitors.
Does Global Longlife Hosp pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Global Longlife Hosp latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Global Longlife Hosp allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Global Longlife Hosp balance sheet?
Global Longlife Hosp balance sheet is weak and might have solvency issues
Is the profitablity of Global Longlife Hosp improving?
The profit is oscillating. The profit of Global Longlife Hosp is -₹1.72 Crs for Mar 2026, ₹0.2 Crs for Mar 2025 and -₹2.19 Crs for Mar 2024
Is the debt of Global Longlife Hosp increasing or decreasing?
Yes, The net debt of Global Longlife Hosp is increasing. Latest net debt of Global Longlife Hosp is -₹34.03 Crs as of Mar-26. This is greater than Mar-25 when it was -₹42.98 Crs.
Is Global Longlife Hosp stock expensive?
Global Longlife Hosp is not expensive. Latest PE of Global Longlife Hosp is 0, while 3 year average PE is 39.3. Also latest EV/EBITDA of Global Longlife Hosp is 0.2 while 3yr average is 11.11.
Has the share price of Global Longlife Hosp grown faster than its competition?
Global Longlife Hosp has given lower returns compared to its competitors. Global Longlife Hosp has grown at ~-35.14% over the last 4yrs while peers have grown at a median rate of 1.96%
Is the promoter bullish about Global Longlife Hosp?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Global Longlife Hosp is 22.88% and last quarter promoter holding is 22.88%.
Are mutual funds buying/selling Global Longlife Hosp?
There is Insufficient data to gauge this.